CRL
Price
$161.64
Change
-$0.89 (-0.55%)
Updated
Nov 19 closing price
Capitalization
7.96B
90 days until earnings call
Intraday BUY SELL Signals
MTD
Price
$1404.43
Change
+$7.98 (+0.57%)
Updated
Nov 19 closing price
Capitalization
28.69B
77 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRL vs MTD

Header iconCRL vs MTD Comparison
Open Charts CRL vs MTDBanner chart's image
Charles River Laboratories International
Price$161.64
Change-$0.89 (-0.55%)
Volume$751.57K
Capitalization7.96B
Mettler-Toledo International
Price$1404.43
Change+$7.98 (+0.57%)
Volume$91.34K
Capitalization28.69B
CRL vs MTD Comparison Chart in %
CRL
Daily Signal:
Gain/Loss:
MTD
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CRL vs. MTD commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRL is a Hold and MTD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (CRL: $161.64 vs. MTD: $1404.43)
Brand notoriety: CRL and MTD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CRL: 68% vs. MTD: 62%
Market capitalization -- CRL: $7.96B vs. MTD: $28.69B
CRL [@Medical Specialties] is valued at $7.96B. MTD’s [@Medical Specialties] market capitalization is $28.69B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRL’s FA Score shows that 1 FA rating(s) are green whileMTD’s FA Score has 3 green FA rating(s).

  • CRL’s FA Score: 1 green, 4 red.
  • MTD’s FA Score: 3 green, 2 red.
According to our system of comparison, MTD is a better buy in the long-term than CRL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRL’s TA Score shows that 4 TA indicator(s) are bullish while MTD’s TA Score has 3 bullish TA indicator(s).

  • CRL’s TA Score: 4 bullish, 6 bearish.
  • MTD’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both CRL and MTD are a bad buy in the short-term.

Price Growth

CRL (@Medical Specialties) experienced а -5.75% price change this week, while MTD (@Medical Specialties) price change was -3.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.75%. For the same industry, the average monthly price growth was -1.62%, and the average quarterly price growth was +29.45%.

Reported Earning Dates

CRL is expected to report earnings on Feb 18, 2026.

MTD is expected to report earnings on Feb 05, 2026.

Industries' Descriptions

@Medical Specialties (-2.75% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MTD($28.7B) has a higher market cap than CRL($7.96B). CRL has higher P/E ratio than MTD: CRL (577.05) vs MTD (34.87). MTD YTD gains are higher at: 14.771 vs. CRL (-12.438). MTD has higher annual earnings (EBITDA): 1.22B vs. CRL (528M). CRL has more cash in the bank: 183M vs. MTD (61.8M). MTD has less debt than CRL: MTD (2.18B) vs CRL (2.79B). CRL (4.03B) and MTD (3.87B) have equivalent revenues.
CRLMTDCRL / MTD
Capitalization7.96B28.7B28%
EBITDA528M1.22B43%
Gain YTD-12.43814.771-84%
P/E Ratio577.0534.871,655%
Revenue4.03B3.87B104%
Total Cash183M61.8M296%
Total Debt2.79B2.18B128%
FUNDAMENTALS RATINGS
CRL vs MTD: Fundamental Ratings
CRL
MTD
OUTLOOK RATING
1..100
6266
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
100
Overvalued
PROFIT vs RISK RATING
1..100
10067
SMR RATING
1..100
873
PRICE GROWTH RATING
1..100
5829
P/E GROWTH RATING
1..100
128
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRL's Valuation (94) in the Miscellaneous Commercial Services industry is in the same range as MTD (100) in the Medical Specialties industry. This means that CRL’s stock grew similarly to MTD’s over the last 12 months.

MTD's Profit vs Risk Rating (67) in the Medical Specialties industry is somewhat better than the same rating for CRL (100) in the Miscellaneous Commercial Services industry. This means that MTD’s stock grew somewhat faster than CRL’s over the last 12 months.

MTD's SMR Rating (3) in the Medical Specialties industry is significantly better than the same rating for CRL (87) in the Miscellaneous Commercial Services industry. This means that MTD’s stock grew significantly faster than CRL’s over the last 12 months.

MTD's Price Growth Rating (29) in the Medical Specialties industry is in the same range as CRL (58) in the Miscellaneous Commercial Services industry. This means that MTD’s stock grew similarly to CRL’s over the last 12 months.

CRL's P/E Growth Rating (1) in the Miscellaneous Commercial Services industry is in the same range as MTD (28) in the Medical Specialties industry. This means that CRL’s stock grew similarly to MTD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRLMTD
RSI
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
65%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
66%
Momentum
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
60%
MACD
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
65%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
63%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
62%
Advances
ODDS (%)
Bullish Trend 9 days ago
70%
Bullish Trend 1 day ago
62%
Declines
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 3 days ago
62%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
75%
Aroon
ODDS (%)
Bullish Trend 1 day ago
67%
Bullish Trend 1 day ago
61%
View a ticker or compare two or three
Interact to see
Advertisement
CRL
Daily Signal:
Gain/Loss:
MTD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CGFEX82.980.43
+0.52%
American Funds Growth Fund of Amer 529E
HNMDX13.13N/A
N/A
Heartland Mid Cap Value Institutional
LAMAX25.21N/A
N/A
Lord Abbett Dividend Growth A
CREAX9.62N/A
N/A
Columbia Real Estate Equity A
USTCX32.17N/A
N/A
Victory Science & Technology Class A

CRL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRL has been loosely correlated with A. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if CRL jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRL
1D Price
Change %
CRL100%
-0.55%
A - CRL
65%
Loosely correlated
+0.39%
RVTY - CRL
65%
Loosely correlated
-0.87%
MTD - CRL
63%
Loosely correlated
+0.57%
TMO - CRL
60%
Loosely correlated
-0.39%
NOTV - CRL
58%
Loosely correlated
-4.13%
More

MTD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MTD has been closely correlated with A. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if MTD jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTD
1D Price
Change %
MTD100%
+0.57%
A - MTD
84%
Closely correlated
+0.39%
RVTY - MTD
80%
Closely correlated
-0.87%
TMO - MTD
79%
Closely correlated
-0.39%
WAT - MTD
77%
Closely correlated
-0.10%
DHR - MTD
72%
Closely correlated
-1.37%
More